Fumitaka Okajima

538 total citations
38 papers, 399 citations indexed

About

Fumitaka Okajima is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Fumitaka Okajima has authored 38 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Fumitaka Okajima's work include Diabetes Management and Research (10 papers), Diabetes Treatment and Management (10 papers) and Pancreatic function and diabetes (6 papers). Fumitaka Okajima is often cited by papers focused on Diabetes Management and Research (10 papers), Diabetes Treatment and Management (10 papers) and Pancreatic function and diabetes (6 papers). Fumitaka Okajima collaborates with scholars based in Japan, United States and Mali. Fumitaka Okajima's co-authors include Hitoshi Sugihara, Shinichi Oikawa, Mototsugu Nagao, Yasushi Nakajima, Naoya Emoto, Hideki Tamura, Kyoko Tanimura, Rei Goto, Akira Asai and Kazuhito Yokoyama and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Arteriosclerosis Thrombosis and Vascular Biology and The American Journal of Cardiology.

In The Last Decade

Fumitaka Okajima

35 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumitaka Okajima Japan 13 185 93 74 61 54 38 399
Şenay Topsakal Türkiye 11 115 0.6× 62 0.7× 37 0.5× 64 1.0× 48 0.9× 49 360
Shohei Matsuno Japan 11 123 0.7× 105 1.1× 136 1.8× 88 1.4× 80 1.5× 24 484
Mohsen Firoozrai Iran 14 118 0.6× 69 0.7× 121 1.6× 65 1.1× 95 1.8× 42 424
Adriana Marton United States 7 124 0.7× 71 0.8× 46 0.6× 73 1.2× 124 2.3× 12 426
Ichiro Chinen Japan 5 143 0.8× 43 0.5× 98 1.3× 77 1.3× 98 1.8× 5 342
George B. Kudolo United States 15 114 0.6× 64 0.7× 39 0.5× 66 1.1× 53 1.0× 28 536
Ron T. Varghese United States 11 151 0.8× 129 1.4× 45 0.6× 88 1.4× 75 1.4× 29 406
Thiago MC Pereira Brazil 8 84 0.5× 48 0.5× 67 0.9× 106 1.7× 79 1.5× 9 406
Chuchun L. Chang United States 14 96 0.5× 126 1.4× 87 1.2× 107 1.8× 92 1.7× 25 502
Rodolfo Grella Italy 10 156 0.8× 110 1.2× 56 0.8× 93 1.5× 114 2.1× 12 418

Countries citing papers authored by Fumitaka Okajima

Since Specialization
Citations

This map shows the geographic impact of Fumitaka Okajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumitaka Okajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumitaka Okajima more than expected).

Fields of papers citing papers by Fumitaka Okajima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumitaka Okajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumitaka Okajima. The network helps show where Fumitaka Okajima may publish in the future.

Co-authorship network of co-authors of Fumitaka Okajima

This figure shows the co-authorship network connecting the top 25 collaborators of Fumitaka Okajima. A scholar is included among the top collaborators of Fumitaka Okajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumitaka Okajima. Fumitaka Okajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamaguchi, Yuji, et al.. (2023). Atypical Clinical Courses of Graves' Disease Confound Differential Diagnosis of Hyperthyroidism. Journal of Nippon Medical School. 91(1). 48–58. 1 indexed citations
2.
Ishibashi, Ryoichi, Atsuko Watanabe, Tetsuya Yamamoto, et al.. (2021). Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Type 1 Diabetes Mellitus on Body Composition and Glucose Variabilities: Single-Arm, Exploratory Trial. Diabetes Therapy. 12(5). 1415–1427. 6 indexed citations
3.
Emoto, Naoya, et al.. (2021). Risk Preferences, Rationality of Choices, and Willingness to Pay for Preventive Medicine in Patients with Graves’ Thyrotoxicosis. Patient Preference and Adherence. Volume 15. 1971–1979.
5.
Okajima, Fumitaka, et al.. (2020). New-onset graves’ disease after the initiation of nivolumab therapy for gastric cancer: a case report. BMC Endocrine Disorders. 20(1). 132–132. 14 indexed citations
7.
Shirakabe, Akihiro, M. Matsushita, Hirotake Okazaki, et al.. (2020). Empagliflozin Administration Can Decrease the Dose of Loop Diuretics and Prevent the Exacerbation of Renal Tubular Injury in Patients With Compensated Heart Failure Complicated by Diabetes. Circulation Reports. 2(10). 565–575. 14 indexed citations
8.
Matsushita, M., Akihiro Shirakabe, Nobuaki Kobayashi, et al.. (2020). Mechanisms of Urgently Presenting Acute Heart Failure. International Heart Journal. 61(2). 316–324. 2 indexed citations
9.
Noh, Jaeduk Yoshimura, et al.. (2019). Painless destructive thyroiditis in a patient with resistance to thyroid hormone: a case report. Thyroid Research. 12(1). 8–8.
10.
Asai, Kuniya, Akihiro Shirakabe, Nobuaki Kobayashi, et al.. (2019). Relation of Low Triiodothyronine Syndrome Associated With Aging and Malnutrition to Adverse Outcome in Patients With Acute Heart Failure. The American Journal of Cardiology. 125(3). 427–435. 20 indexed citations
11.
Kurihara, Osamu, Fumitaka Okajima, Masamichi Takano, et al.. (2018). Postprandial Hyperchylomicronemia and Thin-Cap Fibroatheroma in Nonculprit Lesions. Arteriosclerosis Thrombosis and Vascular Biology. 38(8). 1940–1947. 7 indexed citations
12.
Okajima, Fumitaka, Osamu Kurihara, Masamichi Takano, Hitoshi Sugihara, & Naoya Emoto. (2018). Postprandial Hyperchylomicronemia and Thin-Cap Fibroatheroma in Non-culprit Lesions: a Multivessel Optical Coherence Tomography Study. Atherosclerosis Supplements. 32. 41–42.
13.
Oikawa, Shinichi, et al.. (2018). Frequency of achilles tendon xanthoma in patients with acute coronary syndrome. Atherosclerosis. 275. e149–e150. 1 indexed citations
14.
Okajima, Fumitaka, Yuko Nakamura, Yuji Yamaguchi, et al.. (2018). Basal–Bolus Insulin Therapy with Gla-300 During Hospitalization Reduces Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study. Diabetes Therapy. 9(3). 1049–1059. 4 indexed citations
15.
Shirakabe, Akihiro, Noritake Hata, Nobuaki Kobayashi, et al.. (2018). Decreased blood glucose at admission has a prognostic impact in patients with severely decompensated acute heart failure complicated with diabetes mellitus. Heart and Vessels. 33(9). 1008–1021. 6 indexed citations
16.
Sato, Yuki, Mototsugu Nagao, Akira Asai, et al.. (2013). Association of glycated albumin with the presence of carotid plaque in patients with type 2 diabetes. Journal of Diabetes Investigation. 4(6). 634–639. 13 indexed citations
18.
Nakajima, Yasushi, Kazumi Sato, Mototsugu Nagao, et al.. (2010). Practical Dietary Calorie Management, Body Weight Control and Energy Expenditure of Diabetic Patients in Short-term Hospitalization. Journal of Atherosclerosis and Thrombosis. 17(6). 558–567. 12 indexed citations
19.
Tanimura, Kyoko, Yasushi Nakajima, Mototsugu Nagao, et al.. (2008). Association of serum apolipoprotein B48 level with the presence of carotid plaque in type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 81(3). 338–344. 23 indexed citations
20.
Akira, Kazuki, et al.. (2006). Inhibitory Effects of Amlodipine and Fluvastatin on the Deposition of Advanced Glycation End Products in Aortic Wall of Cholesterol and Fructose-Fed Rabbits. Biological and Pharmaceutical Bulletin. 29(1). 75–81. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026